The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comparison of neoadjuvant TP (nTP; docetaxel, T; cisplatin, P) versus nTPF in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC).
J. Fayette
No relevant relationships to disclose
E. Lavergne
No relevant relationships to disclose
S. Chabaud
No relevant relationships to disclose
B. Favier
No relevant relationships to disclose
D. Girodet
No relevant relationships to disclose
P. Zrounba
No relevant relationships to disclose